Labrador Iron Ore Royalty Corp (LIF)
Toronto Exchange · Canada · prices in CAD · close of 23 Oct 2026
Key indicators
| Last close | CAD 20.52 |
|---|---|
| 52-week range | 20.50 – 31.97 |
| Return, 1 month / 3 months | −18.9% / −19.5% |
| Return, 1 year / 3 years | −23.4% / −17.2% |
| Trend | Below its 200-day average |
| RSI (14) | 23 |
| Volatility (1 year) | 22.7% |
| Worst drawdown (1 year) | -33.4% |
| Average daily value traded | 5.46M CAD |
| Dividend yield | 6.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Labrador Iron Ore Royalty Corporation is a royalty company based in Canada that holds interests tied to the Iron Ore Company of Canada. Through its royalty arrangement, it receives payments based on iron ore produced and shipped from the Carol Lake mining operations in Labrador, and it also holds an equity interest in that operating company. Its income comes from these royalty and equity interests rather than from mining operations of its own, and its activities centre on the iron ore business in eastern Canada.
Labrador Iron Ore Royalty Corp trades under the code LIF on the Toronto Exchange in Canada, with its price quoted in Canadian dollars (CAD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Labrador Iron Ore Royalty Corp (LIF) trades on the Toronto Exchange in Canada. It last closed at CAD 20.52 on 23 October 2026.
Its price-based Market X-Ray is 45 out of 100 (a weak price profile), ranking 554 of 870 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 23.4% and over the last three months it fell 19.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Toronto Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 21 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -24.4% | ||
| From 52-week high | -35.6% | ||
| Momentum | 21 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -19.5% | ||
| 6-month return | -25.6% | ||
| 12-month return, skipping the last month | -5.6% | ||
| Stability (higher is calmer) | 65 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 22.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -33.4% | ||
| Liquidity | 72 · Strong | Trades actively. | |
| Average daily value traded | 5.46M CAD | ||
| Zero-volume days | 0.0% | ||
| Income | 74 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 6.1% | ||
| Years with dividends | 6 |
Strengths
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −3.8% |
|---|---|
| 1 month | −18.9% |
| 3 months | −19.5% |
| 6 months | −25.6% |
| 1 year | −23.4% |
| 3 years | −17.2% |
| 5 years | −17.4% |
Signals
| 50-day / 200-day average | 24.50 / 27.15 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.57 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 Sep 2026 | CAD 0.3000 |
| 30 Jun 2026 | CAD 0.3000 |
| 31 Mar 2026 | CAD 0.3000 |
| 31 Dec 2025 | CAD 0.3500 |
| 29 Sep 2025 | CAD 0.4000 |
| 30 Jun 2025 | CAD 0.3000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Toronto Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.